A minimal common outcome measure set for COVID-19 clinical researchJohn C. Marshall, Halima Salisu-Kabara, Menno D. de Jong et al.|The Lancet Infectious Diseases|2020Cited by 1.8k
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant dataStella G. Muthuri, Elga Mayo-Montero, Sudhir Venkatesan et al.|The Lancet Respiratory Medicine|2014Cited by 648
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis NetworkGiovanni Battista Migliori, José-María García-García, Simon Tiberi et al.|International Journal of Infectious Diseases|2020Cited by 226
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportBorisov Se, Valentina Marchese, Edvardas Danila et al.|European Respiratory Journal|2019Cited by 176
Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, AustraliaAdrian R Tramontana, Monica A. Slavin, Biju George et al.|Emerging infectious diseases|2010Cited by 140